Heart Success: Dr. Carolyn Lam and Dr. C. Michael Gibson Talk About Success in the Battle Against Heart Failure November 20, 2020 Disclosures: TBA
Dr. John Teerlink and Dr. C. Michael Gibson Discuss: Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: The Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure (GALACTIC-HF) Trial November 17, 2020 Disclosures: TBA
Dr. Robert Harrington and Dr. C. Michael Gibson Discuss: The AHA COVID-19 Cardiovascular Disease Registry: Design, Implementation, and Initial Results November 17, 2020 Disclosures: TBA
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: AHA 2020 Daily Wrap-Up – November 16, 2020 November 16, 2020 Disclosures: TBA
Dr. Steven Steinhubl and Dr. C. Michael Gibson Discuss: 3-year Clinical Outcomes In A Nationwide, Randomized, Pragmatic Clinical Trial Of Atrial Fibrillation Screening – Mhealth Screening To Prevent Strokes (mstops) November 16, 2020
Dr. Deepak Bhatt and Dr. C. Michael Gibson Discuss: The SOLOIST-WHF and SCORED Trials: Sotagliflozin in Diabetes Patients November 16, 2020 Disclosures: TBA
Dr. A. Michael Lincoff and Dr. C. Michael Gibson Discuss: STRENGTH Trial: Cardiovascular Outcomes With Omega-3 Carboxylic Acids (Epanova) In Patients With High Vascular Risk And Atherogenic Dyslipidemia November 15, 2020
Dr. Otavio Berwanger and Dr. C. Michael Gibson Discuss: Rivaroxaban Versus Warfarin In Patients With Bioprosthetic Mitral Valves And Atrial Fibrillation Or Flutter: Primary Results From The RIVER Randomized Trial November 14, 2020 Disclosures: TBA
Dr. Renato Lopes and Dr. C. Michael Gibson Discuss: Rivaroxaban Versus Warfarin In Patients With Bioprosthetic Mitral Valves And Atrial Fibrillation Or Flutter: Primary Results From The RIVER Randomized Trial November 14, 2020
Dr. Prem Pais and Dr. Serge Korjian Discuss: A Polypill For Primary Prevention Of Cardiovascular Disease In Intermediate Risk People: Results Of The International Polycap Study (TIPS)-3 November 13, 2020
